DRUG: LP-168
DRUG: LP-168
DRUG: Pembrolizumab
DRUG: R-CHOP Protocol
DRUG: Belinostat
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Pharmacokinetic Study
PROCEDURE: Positron Emission Tomography and Computed Tomography Scan
DRUG: Tazemetostat
DRUG: Odronextamab
DRUG: AVM0703
GENETIC: ADI-001
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
PROCEDURE: Computed Tomography
RADIATION: External Beam Radiation Therapy
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
PROCEDURE: Bone Marrow Biopsy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
BIOLOGICAL: Retifanlimab
BIOLOGICAL: Rituximab and Hyaluronidase Human
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Multigated Acquisition Scan
OTHER: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Biospecimen Collection
DRUG: Polatuzumab Vedotin
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
DRUG: Acalabrutinib
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: ABBV-525
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Rituximab
DRUG: CTO1681 10 μg
DRUG: CTO1681 20 μg
DRUG: CTO1681 30 μg
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
DRUG: Polymer-conjugated IL-15 Receptor Agonist NKTR-255
PROCEDURE: X-Ray Imaging
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Lumbar Puncture
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Biopsy
DIETARY_SUPPLEMENT: Cholecalciferol
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
DRUG: Tegavivint
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Loncastuximab Tesirine
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Positron Emission Tomography
GENETIC: KUR-502
DRUG: DA-EPOCH
BIOLOGICAL: Rituximab
DRUG: CHOP
DRUG: Acalabrutinib
DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
DRUG: rituximab and lenalidomide
DRUG: rituximab and bendamustine
DRUG: rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin
DRUG: gemcitabine and oxaliplatin
BIOLOGICAL: Epcoritamab
DRUG: rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone
DRUG: Lenalidomide
DRUG: rituximab, ifosfamide, carboplatin, and etoposide phosphate
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
BIOLOGICAL: Epcoritamab
DRUG: E7777
DRUG: Prednisone
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Epcoritamab
DRUG: Polatuzumab Vedotin
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
BIOLOGICAL: Filgrastim
DRUG: NX-2127
BIOLOGICAL: Axicabtagene Ciloleucel
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
BIOLOGICAL: Mosunetuzumab
OTHER: Patient Observation
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
DRUG: voruciclib monotherapy
DRUG: voruciclib and venetoclax
DRUG: Selinexor
BIOLOGICAL: CNTY-101
BIOLOGICAL: IL-2
DRUG: Lymphodepleting Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Pneumococcal conjugate vaccine (PCV13)
BIOLOGICAL: CD19 targeted CAR T Cell Therapy
DRUG: CD47 Antagonist ALX148
DRUG: Lenalidomide
BIOLOGICAL: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Tafasitamab
DRUG: Tazemetostat
DRUG: Zanubrutinib
DRUG: RNK05047
DRUG: Polatuzumab vedotin
DRUG: AZD0486 IV
DRUG: Fludarabine (Conditional therapy)
DRUG: Cyclophosphamide Monohydrate (Conditional therapy)
DRUG: firi-cel (Experimental drug)
DRUG: DPX-Survivac
DRUG: Pembrolizumab
DRUG: CPA
BIOLOGICAL: Zilovertamab vedotin
BIOLOGICAL: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Bendamustine
PROCEDURE: AutoSCT OR CAR T-cell Therapy
DRUG: GDP
DRUG: Epcoritamab
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Relatlimab
DRUG: Nivolumab
DRUG: Mosunetuzumab
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: ABBV-319
DRUG: Efineptakin alfa
DRUG: Tisagenlecleucel
DRUG: Axicabtagene ciloleucel
DRUG: Lisocabtagene Maraleucel
DRUG: Acalabrutinib
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Lenalidomide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
DRUG: Choline Salicylate
DRUG: Selinexor
DRUG: ATA3219
DRUG: SC291
DRUG: Tazemetostat Pill
DRUG: Iopofosine I 131 single dose
DRUG: Iopofosine I 131 multiple dose
DRUG: Iopofosine I 131 fractionated dose
DRUG: Loncastuximab Tesirine
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Decitabine and Cedazuridine
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Zanubrutinib
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Tocilizumab
DRUG: Rituximab
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: BGB-16673
DRUG: 131-I Apamistamab
BIOLOGICAL: CAR T-cell
DRUG: IKS03
PROCEDURE: Biospecimen Collection
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Oral Azacitidine
DRUG: Prednisone
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: SGN-35C
DRUG: EZM0414
DIETARY_SUPPLEMENT: Ascorbic Acid
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: Gemcitabine Hydrochloride
DRUG: Ifosfamide
OTHER: Laboratory Biomarker Analysis
DRUG: Oxaliplatin
OTHER: Placebo Administration
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Decitabine
PROCEDURE: Biospecimen Collection
PROCEDURE: Core Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Central Venous Cannula Insertion
PROCEDURE: Portacath Placement
PROCEDURE: Computed Tomography
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Golcadomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Ontorpacept
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Maplirpacept
DRUG: mosunetuzumab
DRUG: glofitamab
DRUG: obinutuzumab
BIOLOGICAL: obinutuzumab
DRUG: prednisone
DRUG: Revlimid
BIOLOGICAL: Polatuzumab
DRUG: ibrutinib
DRUG: venetoclax
DRUG: ACALABRUTINIB
DRUG: LISOCABTAGENE MARALEUCEL
DRUG: Lymphodepleting chemotherapy
DRUG: Duvelisib
BIOLOGICAL: Tisagenlecleucel
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: ABBV-101
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Oral MRT-2359
DRUG: Venetoclax
DRUG: Ibrutinib
DRUG: Prednisone
BIOLOGICAL: Obinutuzumab
DRUG: Revlimid (lenalidomide)
DRUG: Epcoritamab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
BIOLOGICAL: Lisocabtagene Maraleucel
PROCEDURE: Lymph Node Biopsy
PROCEDURE: Positron Emission Tomography
DRUG: Zanubrutinib
BIOLOGICAL: zamtocabtagene autoleucel (MB-CART2019.1)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
BIOLOGICAL: bbT369
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
DRUG: Cyclophosphamide
BIOLOGICAL: Daratumumab
DRUG: Doxorubicin
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Prednisone
DRUG: Vincristine
DRUG: Vincristine Sulfate
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
DRUG: Lenalidomide
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
DRUG: Methotrexate
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
PROCEDURE: Ultrasound Imaging
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
BIOLOGICAL: ONCT-808
DRUG: Bridging Therapy
DRUG: Acalabrutinib
BIOLOGICAL: Rituximab
DRUG: Acalabrutinib
DRUG: SGR-1505
DRUG: CD79b-19 CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Itacitinib
BIOLOGICAL: Chimeric antigen receptor (CAR) T-cell therapy
RADIATION: Bridging radiation therapy
BIOLOGICAL: Liso-cel
RADIATION: Post-infusion radiation
DRUG: IMPT-314
DRUG: AC676
DRUG: NKTR-255 at 1.5 µg/kg
DRUG: NKTR-255 at 3.0 μg/kg
DRUG: NKTR-255 at 3.0/6.0 μg/kg
OTHER: Placebo Comparator
DRUG: IMT-009
COMBINATION_PRODUCT: Fruquintinib
DRUG: NX-1607
DRUG: Paclitaxel
DRUG: maplirpacept (PF-07901801)
DRUG: Glofitamab
DRUG: Obinutuzumab
DRUG: Glofitamab
DRUG: Polatuzumab
DRUG: Rituximab
DRUG: Doxorubicin Hydrochloride
DRUG: Cyclophosphamide
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
BIOLOGICAL: Loncastuximab Tesirine
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: SC262
DRUG: Nanatinostat in combination with valganciclovir
BIOLOGICAL: Loncastuximab Tesirine
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Myeloablative Conditioning
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lenalidomide
BIOLOGICAL: Mosunetuzumab
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
DRUG: ONM-501
DRUG: Cemiplimab
DRUG: Mosunetuzumab
DRUG: DHAX
DRUG: ICE
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab Prednisone
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: SYNCAR-001
DRUG: STK-009
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: P-CD19CD20-ALLO1
DRUG: Rimiducid
BIOLOGICAL: GEN3014
DRUG: Daratumumab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin
PROCEDURE: Echocardiography
DRUG: Etoposide
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mosunetuzumab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine
RADIATION: Adaptive Bridging Radiation Therapy (ABRT)
DRUG: Prednisone
DRUG: Prednisolone
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Polatuzumab Vedotin
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: SGN-35T
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Epcoritamab
DRUG: Venetoclax
DRUG: Tazemetostat
DRUG: Pembrolizumab
DRUG: Lymphodepletion Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion
PROCEDURE: Leukapheresis
BIOLOGICAL: Anti-CD19 CAR-T cells
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Selinexor (combination therapy)
DRUG: Placebo matching for Selinexor (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Rituximab (combination therapy)
DRUG: Gemcitabine (combination therapy)
DRUG: Dexamethasone (combination therapy)
DRUG: Cisplatin (combination therapy)
DRUG: Selinexor (continuous therapy)
DRUG: Placebo matching for Selinexor (continuous therapy)
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
BIOLOGICAL: Filgrastim
DRUG: Ibrutinib
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pegfilgrastim
OTHER: Pharmacological Study
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: BMF-219
DRUG: NX-5948
DRUG: Belantamab Mafodotin
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Zanubrutinib
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
GENETIC: cemacabtagene ansegedleucel
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DEVICE: Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
DRUG: Polatuzumab vedotin (PV)
DRUG: Rituximab
DRUG: Hyaluronidase
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Dexamethasone
DRUG: GCSF
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
DRUG: Odronextamab
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone/Prednisolone
DRUG: Epcoritamab
DRUG: Lenalidomide
DRUG: Ibrutinib
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride [HCl]
DRUG: Prednisone
DRUG: Polatuzumab Vedotin
DRUG: Venetoclax
DRUG: CC-99282
DRUG: Epcoritamab
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: CPI-0209
DRUG: Isavuconazole
DRUG: TEDDI
BIOLOGICAL: Rituximab
DRUG: Cytarabine
DRUG: TEDD
DRUG: Ibrutinib (Arms 2, 3 and 4)
DRUG: Methotrexate
DRUG: Ibrutinib (Arm 1 - Closed with Amendment G)
DRUG: Ibrutinib (Arm 4)
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Diffuse Large B Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:
![Regeneron](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRegeneron_logo_(2).svg_64899492-87cd-4df9-9d4b-07f9618df890.png?alt=media)
![Bristol Myers Squibb](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FBristol%20Myers%20Squibb_f22fa9b6-b205-4828-bea5-d645566d3243.png?alt=media)